Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Amgen posts ROCKET-SHUTTLE Phase 3 rocatinlimab results; Neulasta label updated; AMG 691 trial opensAug 6Weekly roundup, 3 itemsAMG-691Amgen